Profile Image

Staff Profile

Edit

Career Summary

Qualifications

  • PhD (Medicine), University of Newcastle, 28/08/1998
  • Graduate Diploma in Clinical Epidemiology, University of Newcastle, 11/12/2006
  • Bachelor of Science (Honours), University of Newcastle, 06/05/1994

Research

Research keywords

  • Cardiovascular Medicine
  • Haematology

Research expertise

Genetic susceptibility to disease and treatment toxicity, Mechanisms of snakebite coagulopathy, Investigating the function of circulating microparticles, Investigating a novel target on the surface of leukaemia cells, Epigenetics of atherothrombotic disease.

Fields of Research

CodeDescriptionPercentage
110300Clinical Sciences40
110200Cardiovascular Medicine And Haematology30
060499Genetics Not Elsewhere Classified30
Edit

Highlighted Publications

For publications that are currently unpublished or in-press, details are shown in italics.

YearCitationAltmetricsLink
2001Lincz L, Yeh T-X, Spencer A, 'TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy', Leukemia, 15 1650-1657 (2001) [C1]
2003Lincz L, Scorgie FE, Kerridge I, Potts R, Spencer A, Enno A, 'Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma', British Journal of Haematology, 120 1051-1054 (2003) [C1]

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Journal article (54 outputs)

YearCitationAltmetricsLink
2014Lincz LF, Scorgie FE, Johnston CI, O'Leary M, Prasad R, Seldon M, et al., 'Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venom.', Pathology, 46 444-449 (2014) [C1]
2014Pundavela J, Demont Y, Jobling P, Lincz LF, Roselli S, Thorne R, et al., 'ProNGF Correlates with Gleason Score and Is a Potential Driver of Nerve Infiltration in Prostate Cancer.', Am J Pathol, (2014)
2014Phang M, Scorgie FE, Seldon M, Garg ML, Lincz LF, 'Reduction of prothrombin and Factor V levels following supplementation with omega-3 fatty acids is sex dependent: a randomised controlled study', Journal of Nutritional Biochemistry, (2014)
2014Clancy P, Lincz LF, Maguire J, McEvoy M, Koblar SA, Golledge J, 'Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery.', Biofactors, 40 448-457 (2014)
2014Golledge J, Clancy P, Maguire J, Lincz L, Koblar S, Mcevoy M, et al., 'Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence', Stroke, 45 1064-1068 (2014)
2014Golledge J, Clancy P, Maguire J, Lincz L, Koblar S, McEvoy M, et al., 'Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence', Stroke, (2014)
2013Ardjmand A, de Bock CE, Shahrokhi S, Lincz LF, Boyd AW, Burns GF, Thorne RF, 'Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia', HEMATOLOGY, 18 315-321 (2013) [C1]
2013Isbister GK, Buckley NA, Page CB, Scorgie FE, Lincz LF, Seldon M, Brown SGA, 'A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18)', Journal of Thrombosis and Haemostasis, 11 1310-1318 (2013) [C1]
2013Maduwage K, Scorgie FE, Silva A, Shahmy S, Mohamed F, Abeysinghe C, et al., 'Hump-nosed pit viper (Hypnale hypnale) envenoming causes mild coagulopathy with incomplete clotting factor consumption', CLINICAL TOXICOLOGY, 51 527-531 (2013) [C1]
2013Phang M, Lincz LF, Garg ML, 'Eicosapentaenoic and Docosahexaenoic Acid Supplementations Reduce Platelet Aggregation and Hemostatic Markers Differentially in Men and Women', JOURNAL OF NUTRITION, 143 457-463 (2013) [C1]
2013Alkhatatbeh MJ, Enjeti AK, Acharya S, Thorne RF, Lincz LF, 'The origin of circulating CD36 in type 2 diabetes', NUTRITION & DIABETES, 3 (2013) [C1]
2012Cheng YC, Anderson CD, Bione S, Keene K, Maguire JM, Nalls M, et al., 'Are myocardial infarction-associated single-nucleotide polymorphisms associated with ischemic stroke?', Stroke, 43 980-U143 (2012) [C1]
2012Phang M, Sinclair AJ, Lincz L, Garg ML, 'Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation', Nutrition Metabolism and Cardiovascular Diseases, 22 109-114 (2012) [C1]

Co-authors: Manohar Garg

2012Phang M, Lincz L, Seldon M, Garg ML, 'Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects', Journal of Nutritional Biochemistry, 23 1128-1133 (2012) [C1]

Co-authors: Manohar Garg

2012Lincz L, Scorgie FE, Enjeti A, Seldon M, 'Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden', Thrombosis Research, 129 192-196 (2012) [C1]
2012Holliday EG, Maguire JM, Evans T-J, Koblar SA, Jannes J, Sturm J, et al., 'Common variants at 6p21.1 are associated with large artery atherosclerotic stroke', Nature Genetics, 44 1147-1153 (2012) [C1]
2012Garg MB, Lincz L, Adler K, Scorgie FE, Ackland S, Sakoff JA, 'Predicting 5-Fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length - A multivariate analysis', British Journal of Cancer, 107 1525-1533 (2012) [C1]
2012De Bock CE, Ardjmand Ghahestani A, Molloy TJ, Bone SM, Johnstone DM, Campbell DM, et al., 'The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia', Leukemia, 26 918-926 (2012) [C1]

Co-authors: Rick Thorne

2011McGettigan P, Lincz L, Attia JR, McElduff P, Bissett L, Peel R, et al., 'The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene', British Journal of Clinical Pharmacology, 72 707-714 (2011) [C1]
2011Maguire JM, Thakkinstian A, Levi CR, Lincz L, Bisset L, Sturm J, et al., 'Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: A novel finding', Journal of Stroke and Cerebrovascular Diseases, 20 134-144 (2011) [C1]
2011Golledge J, Clancy P, Maguire JM, Lincz L, Koblar S, 'The role of tenascin C in cardiovascular disease', Cardiovascular Research, 92 19-28 (2011) [C1]
2011Alkhatatbeh MJ, Mhaidat NM, Enjeti AK, Lincz L, Thorne RF, 'The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles', Journal of Thrombosis and Haemostasis, 9 844-851 (2011) [C1]
2010De Bock CE, Garg ML, Scott NM, Sakoff JA, Scorgie FE, Ackland S, Lincz L, 'Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo', Pharmacogenomics Journal, 1-8 (2010) [C1]
2010Isbister GK, Scorgie FE, O'Leary MA, Seldon M, Brown SGA, Lincz L, 'Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10)', Journal of Thrombosis and Haemostasis, 8 2504-2513 (2010) [C1]
2010Enjeti A, Lincz L, Scorgie FE, Seldon MR, 'Circulating microparticles are elevated in carriers of Factor V Leiden', Thrombosis Research, 126 250-253 (2010) [C1]
2010Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, Lincz L, 'Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom', Toxicon, 56 75-85 (2010) [C1]
2009Lincz L, Gupta SA, Wratten C, Kilmurray J, Nash S, Seldon M, et al., 'Thrombin generation as a predictor of radiotherapy induced skin erythema', Radiotherapy and Oncology, 90 136-140 (2009) [C1]
2009Isbister GK, Scorgie FE, Seldon MR, Lincz L, 'Clinical relevance of brown snake (Pseudonaja spp) factor V escaping hemostatic regulation', Blood, 114 2563 (2009) [C3]
2008Enjeti AK, Lincz L, Seldon MR, 'Microparticles in health and disease', Seminars in Thrombosis and Haemostasis, 34 683-692 (2008) [C1]
2008Lincz L, Mudge L-M, Scorgie FE, Sakoff JA, Hamilton C, Seldon MR, 'Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the [beta symbol] deletion variant', Neoplasia, 10 1131-1137 (2008) [C1]
2008Enjeti AK, Lincz L, Seldon MR, 'Bio-maleimide as a generic stain for detection and quantitation of microparticles', International Journal of Laboratory Hematology, 30 196-199 (2008) [C1]
2008Maguire JM, Thakkinstian A, Sturm J, Levi CR, Lincz L, Parsons MW, et al., 'Polymorphisms in platelet glycoprotein 1b [alpha] and factor VII and risk of ischemic stroke', Stroke, 39 1710-1716 (2008) [C1]
2007Attia JR, Thakkinstian A, Wang Y, Lincz L, Parsons MW, Sturm J, et al., 'The PAI-1 4G/5G gene polymorphism and ischemic stroke: An association study and meta-analysis', Journal of Stroke and Cerebrovascular Diseases, 16 173-179 (2007) [C1]
2007Au GG, Lincz L, Enno A, Shafren DR, 'Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma', British Journal of Haematology, 137 133-141 (2007) [C1]
2007Lincz L, Scorgie FE, Garg MB, Ackland S, 'Identification of a novel single nucleotide polymorphism in the second tandem repeat sequence of the thymidylate synthase 2R allele', International Journal of Cancer, 120 1930-1934 (2007) [C1]
2007Lincz L, Adams MJ, Scorgie FE, Thom J, Baker RI, Seldon M, 'Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden', Blood Coagulation & Fibrinolysis, 18 559-564 (2007) [C1]
2007Enjeti AK, Lincz L, Seldon M, 'Detection and measurement of microparticles: An evolving research tool for vascular biology', Seminars in Thrombosis and Hemostasis, 33 771-779 (2007) [C1]
2007Lincz L, Scorgie FE, Robertson R, Enno A, 'Genetic variations in benzene metabolism and susceptibility to multiple myeloma', Leukemia Research, 31 759-763 (2007) [C1]
2007Lincz L, Scorgie FE, Garg ML, Ackland S, 'Reply to the letter to the editor 'Classification of thymidylate synthase gene enhancer region polymorphisms'', International Journal of Cancer, 121 2581-2582 (2007) [C3]
2006Lincz L, Lonergan A, Scorgie FE, Rowlings PA, Gibson R, Lawrie A, Seldon MR, 'Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of Factor V Leiden', Pathophysiology of Haemostatis and Thrombosis, 35 435-439 (2006) [C1]
2004Lincz L, Scorgie F, Sakoff J, Fagan K, Ackland S, Enno A, 'Telomere length predicts neutrophil recovery in absence of G-CSF after autologous peripheral blood stem cell transplantation', Bone Marrow Transplant, 34 439-445 (2004) [C1]
2004Lincz L, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A, 'Xenobiotic gene polymorphisms and susceptibility to multiple myeloma', Haematologica, 89 628-629 (2004) [C3]
2003Lincz L, Scorgie FE, Kerridge I, Potts R, Spencer A, Enno A, 'Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma', British Journal of Haematology, 120 1051-1054 (2003) [C1]
2002Kerridge I, Lincz LF, Scorgie FE, Granter N, Hickey D, Enno A, Spencer A, 'Xenobiotic enzyme polymorphisms and lymphoma susceptibility', Br. J. Haemtol, 118 477-481 (2002) [C1]
2002Sakoff J, De Waal E, Garg M, Denham J, Scorgie F, Enno A, et al., 'Telomere Length in Haemopoietic Stem Cells can be Determined from that of Mononuclear Blood Cells or Whole Blood', Leukemia and Lymphoma, 43(10) 2017-2020 (2002) [C1]
2002Kerridge I, Lincz L, Scorgie F, Hickey D, Granter N, Spencer A, 'Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk', BRITISH JOURNAL OF HAEMATOLOGY, 118 477-481 (2002)
2001Lincz L, Crooks RL, Way SL, Granter N, Spencer A, 'Tumour Kinetics in Multiple Myeloma Before, During, and After Treatment', Leukemia & Lymphoma, 40 373-384 (2001) [C1]
2001Lincz L, Yeh T-X, Spencer A, 'TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy', Leukemia, 15 1650-1657 (2001) [C1]
2000Lincz LF, Yeh TH, Enno A, Spencer A, 'Variations in TRAIL-induced apoptosis of freshly obtained myeloma cells are not related to TRAIL receptor expression or prior chemotherapy.', BLOOD, 96 162A-162A (2000)
2000Lincz LF, Yeh T-H, Enno A, Spencer A, 'Variations in trail-induced apoptosis of freshly obtained myeloma cells are not related to trail receptor expression or prior chemotherapy', Blood, 96 (2000)
1998Lincz L, 'Deciphering the apoptotic pathway: All roads lead to death', Immunology & Cell Biology, 76 1-19 (1998) [C1]
1997Lincz L, Buret A, Burns GF, 'Formation of spheroid structures in a human colon carcinoma cell line involves a complex series of intercellular rearrangements', Differentiation, 61 261-274 (1997) [C1]
1996Dorahy DJ, Lincz LF, Meldrum CJ, Burns GF, 'Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36', BIOCHEMICAL JOURNAL, 319 67-72 (1996)
1995BATES RC, LINCZ LF, BURNS GF, 'INVOLVEMENT OF INTEGRINS IN CELL-SURVIVAL', CANCER AND METASTASIS REVIEWS, 14 191-203 (1995)
Show 51 more

Conference (36 outputs)

YearCitationAltmetricsLink
2013Enjeti A, D'Cruz A, Seldon M, Lincz L, 'Circulating microparticle number and function vary with age: a study of 120 healthy blood donors', JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013) [E3]
2012Lincz L, Johnston CI, Scorgie FE, O'Leary MA, Prasad R, Seldon MR, et al., 'Comparative sensitivity of different commercially available aPTT reagents to a clinically relevant 'coagulation inhibitor'', HAA 2012: 2012 Co-Joint Scientific Meeting. ASTH Posters, Melbourne (2012) [E3]

Co-authors: Geoff Isbister

2012Sakoff JA, Garg MB, Lincz L, Adler K, Scorgie FE, Ackland S, 'Predicting chemotherapy-induced toxicity in cancer patients from peripheral blood telomere length', European Journal of Cancer, Barcelona, Spain (2012) [E3]
2012Phang M, Lincz L, Seldon MR, Garg ML, 'Differential effects of eicosapentaenoic and docosahexaenoic acids on platelet aggregation and hemostatic markers', Proceedings of the Nutrition Society of Australia, Wollongong, NSW (2012) [E3]

Co-authors: Manohar Garg

2012Scorgie FE, Maduwage KP, Lincz L, Shahmy S, Mohamed F, Seldon MR, Isbister GK, 'Comparison of the haemostatic effects of three different procoagulant snake venoms in human envenoming', HAA 2012: 2012 Co-Joint Scientific Meeting. ASTH Posters, Melbourne (2012) [E3]

Co-authors: Geoff Isbister

2012Phang M, Lincz L, Garg ML, 'Omega-3 polyunsaturated fatty acids and platelet function: Sex dependence', Indian Journal of Hypertension, Mumbai, India (2012) [E3]

Co-authors: Manohar Garg

2012Phang M, Lincz L, Garg ML, 'Efficacy of EPA- and DHA- rich oils on platelet function in healthy men and women', Abstracts. International Conference and Exhibition on Nutraceuticals and Functional Foods, Hawaii, USA (2012) [E3]

Co-authors: Manohar Garg

2012Lincz L, 'The nature and origin of circulating CD36 in type 2 diabetes: A role for microparticles', HAA 2012: 2012 Co-Joint Scientific Meeting. Abstracts, Melbourne (2012) [E3]
2012Phang M, Lincz L, Garg ML, 'Eicosapentaenoic acid versus docosahexaenoic acid rich fish oils: Effect on platelet physiological response', Conference Handbook. Food Structures, Digestion and Health Conference, Palmerston North, NZ (2012) [E3]

Co-authors: Manohar Garg

2011Alkhatatbeh MJ, Mhaidat NM, Enjeti AK, Lincz LF, Thorne RF, 'Circulating plasma CD36+microparticles as a marker of type 2 diabetes and its complications', Clinical Biochemistry, Mashhad, Iran (2011) [E3]

Co-authors: Rick Thorne

2011Ardjmand Ghahestani A, De Bock CE, Molloy TJ, Bone SM, Johnstone DM, Campbell DM, et al., 'Altered expression of Fat1 cadherin, a novel tumor marker for acute lymphoblastic leukemia', Clinical Biochemistry, Mashhad, Iran (2011) [E3]

Co-authors: Rick Thorne

2011Phang M, Lincz L, Garg ML, 'Gender specific effects of long-term dietary EPA and DHA supplementation in platelet aggregation in healthy human subjects', Australasian Medical Journal, Queenstown, NZ (2011) [E3]

Co-authors: Manohar Garg

2011Maguire JM, Holliday EG, Sturm J, Golledge J, Lewis M, Koblar S, et al., 'Australian stroke genetics collaborative: Genetic associations with ischaemic stroke functional outcome', International Journal of Stroke, Adelaide, SA (2011) [E3]
2010Phang M, Sinclair AJ, Lincz L, Garg ML, 'Omega-3 polyunsaturated fatty acis inhibit platelet-derived microparticle activiity in healthy human subjects', APSAVD 2010 Congress. AAS 2010 Annual Scientific Meeting. Abstract Book, Cairns, QLD (2010) [E3]

Co-authors: Manohar Garg

2010Phang M, Lincz L, Garg ML, 'Gender specific role of n-3PUFA to inhibit microparticle activity in healthy humans', 15th World Congress on Clinical Nutrition, El Sokhna, Egypt (2010) [E3]

Co-authors: Manohar Garg

2010Maguire JM, Thakkinstian A, Levi CR, Lincz L, Bissett KE, Sturm J, et al., 'Genetic influences on ischemic stroke 90-day functional outcome: A novel association', Circulation, Beijing (2010) [E3]
2010Lincz L, Scorgie F, Phang M, Garg ML, Enjeti A, Seldo M, 'Variability in platelet microparticle profile and aggregation in healthy males and females', Annual Scientific Meeting of the Haematology Society of Australia and New Zealand. Handbook and Program, Auckland, New Zealand (2010) [E3]

Co-authors: Manohar Garg

2010Phang M, Lincz L, Sinclair AJ, Garg ML, 'Platelet-derived microparticle activity is inhibited by omega-3 fatty acid supplementation', Proceedings of the Nutrition Society of Australia, Perth (2010) [E3]

Co-authors: Manohar Garg

2010Sakoff JA, Garg M, Adler K, Scorgie FE, Lincz L, Ackland S, 'Telomere length in peripheral blood mononuclear cells (PBMNC) predicts for leukopenia, neutropenia and mucositis in colorectal cancer patients treated with 5FU', AACR 101st Annual Meeting 2010. Abstracts, Washington, DC (2010) [E3]
2010Sakoff JA, Garg M, Adler K, Scorgie FE, Lincz L, Ackland S, 'Short telomeres in PBMNC predicts for haematological toxicity in colorectal cancer patients treated with 5FU', Sydney Cancer Conference 2010. Profiling Risk, Personalising Treatment and Predicting Outcomes. Conference Program and Abstract Book, Sydney, NSW (2010) [E3]
2009Lincz L, Woods D, Alley S, O'Leary MA, Seldon MR, Isbister GK, 'Endogenous thrombin potential as a novel method for characterisation of procoagulant snake venoms', Journal of Thrombosis and Haemostasis, Boston, MA (2009) [E3]
2009Phang M, Sinclair AJ, Lincz L, Garg ML, 'Differential effects of a single oral dose of EPA or DHA rich fish oil on platelet aggregation in health human subjects', Proceedings of the Nutrition Society of Australia, Newcastle, NSW (2009) [E3]

Co-authors: Manohar Garg

2009Henry D, Lincz L, Attia J, McElduff P, Bisset L, Peel R, et al., 'Polymorphisms in Two Regions of the Cyclo-Oxygenase-2 Gene Associated with Variation in Risk of Coronary Thrombosis with Cyclo-Oxygenase-2 Inhibitors', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009) [E3]
2009Henry D, Lincz L, Attia JR, McElduff P, Bisset L, Peel R, et al., 'Polymorphisms in two regions of the cyclo-oxygenase-2 gene associated with variation in risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors', Basic & Clinical Pharmacology & Toxicology, Edinburgh, UK (2009) [E3]
2009Isbister GK, Scorgie F, Brown SGA, O'Leary MA, Seldon MR, Lincz L, 'Coagulation factor deficiencies associated with venom induced consumption coagulopathy in Australian snake envenoming', Clinical Toxicology, Stockholm, Sweden (2009) [E3]

Co-authors: Geoff Isbister

2009Maguire J, Thakkinstian A, Attia JR, Lincz L, Bisset L, Sturm J, et al., 'Impact of COX-2 RS5275, RS20417 and GPIIIA RS5918 polymorphisms on 90 day ischaemic stroke functional outcome: A novel association', Cerebrovascular Diseases, Stockholm, Sweden (2009) [E3]
2009Phang M, Sinclair AJ, Lincz L, Garg ML, 'Differential effects of dietary EPA or DHA supplementation on platelet aggregation in healthy male and female subjects', Atherosclerosis Society Annual Scientific Meeting 2009: Meeting Book, Melbourne, VIC (2009) [E3]

Co-authors: Manohar Garg

2008Lincz L, Woods D, Alley S, O'Leary MA, Seldon MR, Isbister GK, 'Endogenous thrombin potential (ETP) as a novel method for characterization of procoagulant snake venoms', HAA 2008 HSANZ ANZSBT ASTH: 2008 Annual Scientific Meeting: Abstracts, Perth, WA (2008) [E3]

Co-authors: Geoff Isbister

2008Lincz L, Gupta SA, Wratten CR, Kilmurray J, Nash S, Seldon M, et al., 'Thrombin generation as a predictor of radiotherapy induced skin erythema', HAA 2008 HSANZ ANZSBT ASTH: 2008 Annual Scientific Meeting: Abstracts, Perth, WA (2008) [E3]
2008Zaunders G, Thambar ST, Zhang H, Lincz L, Rowlings PA, 'Laboratory aspects of autologous marrow stem cells used to treat chronic myocardial ischaemia by direct intramyocardial injection', International Journal of Laboratory Hematology, Sydney, NSW (2008) [E3]
2008Enjeti A, Lincz L, Scorgie F, Seldon M, 'Miniature microparticles measuring less than 0.1 um exist in human plasma and contribute to procoagulant activity', International Journal of Laboratory Hematology, Sydney, NSW (2008) [E3]
2008Enjeti A, Scorgie FE, Lincz L, Brown S, Isbister GK, Seldon MR, 'Circulating microparticles in snake bite patients with microangiopathy', 50th ASH Annual Meeting and Exposition. Online Program and Abstracts, San Francisco, CA (2008) [E3]

Co-authors: Geoff Isbister

2007Maguire J, Sturm J, Attia JR, Whyte S, Bisset L, Lincz L, et al., 'A case-control genetic association study to examine platelet glycoprotein polymorphisms and ischaemic stroke risk', Internal Medicine Journal, Perth, Australia (2007) [E3]
2003McRae SJ, Lincz L, Scorgie F, Gibson R, Seldon M, 'The factor V Asp2194Gly polymorphism linked to the HR2 haplotype is associated with decreased factor V levels.', BLOOD 102 Meeting Abstract (2003) [E3]
2003Lincz LF, Kerridge I, Scorgie F, Bailey M, Enno A, Spencer A, 'Xenobiotic gene polymorphisms alter susceptibility to multiple myeloma.', BLOOD, San Diego, CA (2003)
2002Lincz LF, Enno A, 'Thalidomide induced alterations in multiple myeloma cell surface receptor expression do not affect adhesion to bone marrow stroma or correlate with VEGF secretion in vitro.', BLOOD, PHILADELPHIA, PA (2002)
Show 33 more
Edit

Grants and Funding

Summary

Number of grants20
Total funding$1,585,219

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2013 (2 grants)

The genetic determinants of brain haemorrhage associated with stroke thrombolysis$10,000
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor Chris Levi, Professor John Attia, Doctor Liz Holliday, Dr Simon Koblar, Professor Rodney Scott, Conjoint Associate Professor Jonathan Sturm, Associate Professor Jonathan Rosand, Doctor Lisa Lincz, Associate Professor Jane Maguire
SchemeRole
Near MissInvestigator
Total AmountFunding StartFunding Finish
$10,00020132013
GNo:G1300704

The genetic determinants of brain haemorrhage associated with stroke thrombolysis$10,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Chris Levi, Professor John Attia, Doctor Liz Holliday, Dr Simon Koblar, Professor Rodney Scott, Conjoint Associate Professor Jonathan Sturm, Associate Professor Jonathan Rosand, Doctor Lisa Lincz, Associate Professor Jane Maguire
SchemeRole
Near Miss GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020132013
GNo:G1300475

2012 (3 grants)

High-Resolution Isoelectric Phosphoprotein Signalling System for Signalling Research, Biomarker Validation and Drug Development – Equipment Grant$143,394
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Rick Thorne, Professor Xu Dong Zhang, Professor Hubert Hondermarck, Conjoint Professor Stephen Ackland, Doctor Lisa Lincz, Doctor Jennette Sakoff, Emeritus Professor Leonie Ashman
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$143,39420122012
GNo:G1200555

Establishment of Fat1 cadherin as biomarker and unique target for anti-cancer therapy in paediatric acute lymphoblastic leukaemia$20,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Rick Thorne, Doctor Charles De Bock, Doctor Lisa Lincz
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020122012
GNo:G1200222

The genetic determinants of brain haemorrhage associated with stroke thrombolysis$20,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Chris Levi, Professor John Attia, Doctor Liz Holliday, Professor Rodney Scott, Conjoint Associate Professor Jonathan Sturm, Doctor Lisa Lincz
SchemeRole
Near Miss GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020122012
GNo:G1200675

2011 (1 grants)

How chronic psychological distress leads to premature aging$24,800
Funding Body: Hunter Medical Research Institute

Project Team
Associate Professor Eugene Nalivaiko, Doctor Lisa Lincz
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$24,80020112011
GNo:G1000986

2010 (1 grants)

Pathogenic Function of Plasma CD36 Mircroparticles in Mediating Complications of Type 2 Diabetes$98,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Rick Thorne, Doctor Lisa Lincz
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$98,00020102011
GNo:G0900121

2009 (3 grants)

Australian stroke genetics collaborative - Genome-wide association study in ischaemic stroke$1,108,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor Chris Levi, Conjoint Associate Professor Jonathan Sturm, Professor John Attia, Professor Rodney Scott, Doctor Lisa Lincz, Dr Simon Koblar, Professor Pablo Moscato
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$1,108,00020092011
GNo:G0188856

Identification of leukaemic stem cells based upon their expression of a novel surface marker, Fat1$25,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Rick Thorne, Doctor Lisa Lincz
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$25,00020092009
GNo:G0189791

Vascular Ischaemia Study$10,400
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor Chris Levi, Professor John Attia, Professor Rodney Scott, Doctor Michael Seldon, Doctor Lisa Lincz, Conjoint Associate Professor Jonathan Sturm
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$10,40020092009
GNo:G0900120

2008 (3 grants)

Colibri high-performance LED illumination system for fluorescence live cell microscopy$23,225
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Rick Thorne, Dr Charles De Bock, Professor Xu Dong Zhang, Doctor Lisa Lincz, Professor Gordon Burns, Conjoint Professor Peter Hersey, Professor Dirk Van Helden, Conjoint Professor Keith Jones, Professor Roger Smith
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$23,22520082008
GNo:G0188545

Biogenesis of circulating plasma microparticles in the metabolic syndrome$8,450
Funding Body: University of Newcastle

Project Team
Doctor Rick Thorne, Doctor Lisa Lincz
SchemeRole
Pilot GrantInvestigator
Total AmountFunding StartFunding Finish
$8,45020082008
GNo:G0189072

Biogenesis of circulating plasma microparticles in the metabolic syndrome$8,450
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Doctor Rick Thorne, Doctor Lisa Lincz
SchemeRole
Pilot GrantInvestigator
Total AmountFunding StartFunding Finish
$8,45020082008
GNo:G0189385

2007 (1 grants)

A novel adhesive target involved in the survival of leukaemia cells$20,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Rick Thorne, Doctor Lisa Lincz
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020072007
GNo:G0187243

2006 (1 grants)

Overcoming radiation resistance in malignant melanoma$11,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Lisa Lincz, Doctor Jennette Sakoff
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$11,00020062007
GNo:G0186528

2003 (2 grants)

Investigation of mutant p53 and CD40 expression in multiple myeloma cells and response to thalidomide$10,000
Funding Body: University of Newcastle

Project Team
Doctor Lisa Lincz
SchemeRole
Early Career Researcher GrantChief Investigator
Total AmountFunding StartFunding Finish
$10,00020032003
GNo:G0182860

PULSE Education Prize$3,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Lisa Lincz
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$3,00020032003
GNo:G0182735

2001 (1 grants)

Predicting bone marrow regeneration in cancer patients through the use of telomere quantitative (Q)-FISH$10,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Lisa Lincz, Doctor Jennette Sakoff
SchemeRole
Lions Club of StroudChief Investigator
Total AmountFunding StartFunding Finish
$10,00020012001
GNo:G0181502

2000 (2 grants)

Influence of Haematopoetic stem cell telorase activity on bone marrow recovery following myoablative therapy.$20,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Lisa Lincz, Ms Kerry Fagan, Doctor Jennette Sakoff
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00020002000
GNo:G0180171

Newcastle and Hunter Junior Chamber Special Commendation Prize.$1,500
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Lisa Lincz
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,50020002000
GNo:G0180172
Edit

Research Supervision

Number of current supervisions1
Total current UoN PhD EFTSL0.25

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20112019PhD (Medicine)Co-SupervisorInvestigating the Role of Microparticles in Vascular Biology and Haemostasis

Past Supervision

YearProgramSupervisor TypeResearch Title
2013PhD (Medical Biochemistry)Co-SupervisorDifferential Effects of Long Chain Omega-3 Polyunsaturated Fatty Acids on Platelet Aggregation and Hemostatic Variables in Healthy Male Versus Female Subjects
2013PhD(Experimental Pharmacology)Co-SupervisorBiogenesis of Plasma CD36+Microparticles in Human Diabetes and the Metabolic Syndrome
Edit

Dr Lisa Lincz

Work Phone(02) 4921 1844
Cell / Mobile Phone0403492243
Fax(02) 4960 2136
Email
PositionConjoint Senior Lecturer
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaMedical Biochemistry
Office
4.28,
Mater Hospital Level 4 - New Med 2,
Calvary Mater Newcastle, Waratah
URL:www.newcastle.edu.au/profile/lisa-lincz